Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapyAmber Giles(National Institutes of Health), Mark R. Gilbert(National Institutes of Health)Journal for ImmunoTherapy of CancerJune 11, 201810.1186/s40425-018-0371-5Cited by 481SaveCiteExport RISWatch citationsRelated PapersEfficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK|JCI Insight|2019|61